Dermatology News

Dermatology

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Aberer E - The presented data are important because they show that treatment with iloprost influences pathogenetic mechanisms in systemic sclerosis, a disease associated with limited treatment options.

Related Articles

Measures of Response in Clinical Trials of Systemic Sclerosis: The Combined Response Index for Systemic Sclerosis (CRISS) and Outcome Measures in Pulmonary Arterial Hypertension Related to Systemic Sclerosis (EPOSS)
Journal of Rheumatology, 10/15/09    Relevance Score: 72%%

Necrotizing fasciitis in a patient with overlap syndrome of systemic sclerosis and systemic lupus erythematosus
Rheumatology International, 11/16/09    Relevance Score: 68%%

Aerobic Exercise is Safe and Effective in Systemic Sclerosis
International Journal of Sports Medicine, 10/14/09    Relevance Score: 67%%

High frequency ultrasound measurement of digital dermal thickness in systemic sclerosis
Annals of Rheumatic Diseases, 10/23/09    Relevance Score: 66%%

Mechanisms of vascular damage in systemic sclerosis
Autoimmunity, 10/02/09    Relevance Score: 66%%

Today in Dermatopathology...keeping you current

Topical Calcipotriol for Preventive Treatment of Hypertrophic Scars
Archives of Dermatology, 11/25/09

Granulomatous Dermatitis With Pseudoxanthoma Elasticum-Like Changes
Archives of Dermatology, 11/25/09

Unexpected Occurrence of Xeroderma Pigmentosum in an Uncle and Nephew
Archives of Dermatology, 11/25/09


Sponsor

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Send this Summary to a Colleague

Enter email address